Biotronik gets FDA approval for Orsiro drugeluting stent

Biotronik gets FDA approval for Orsiro drug-eluting stent

02:30 EST 25 Feb 2019 | Compelo Medical Devices

Orsiro, which is claimed to be the first and only ultrathin DES, secured CE mark approval in 2011 and has so far been used to treat over one

The post Biotronik gets FDA approval for Orsiro drug-eluting stent appeared first on Compelo Medical Devices.

Original Article: Biotronik gets FDA approval for Orsiro drug-eluting stent

More From BioPortfolio on "Biotronik gets FDA approval for Orsiro drug-eluting stent"